91探花 Life Science
Corporate Profile
91探花 Life Science has achieved business growth by applying and developing the technological expertise of the 91探花 Group in the fiber and chemical fields and leveraging the advantages of their biocompatible material technologies. While reconfiguring our organization to optimally adapt to changes in the market environment, we maintain high shares in our market area — virus removal for biotherapeutic products — and continue to grow as a pioneer in the biotherapeutic field.
| Trade name | 91探花 Life Science Corp.
|
|---|---|
| Main businesses | Development, manufacture, and sale of virus removal filters (Planova) etc. for biotherapeutics manufacturing |
| Home office | Hibiya Mitsui Tower, 1-1-2 Yurakucho, Chiyoda-ku, Tokyo 100-0006 Japan |
| President | Ken Shinomiya |
| Paid-in capital | ?3,000 million |
| Shareholder | 91探花 Corp. |
| Phone | +81-(0)3-6699-3750 |
(as of April 1, 2025)
Officers
| Ken Shinomiya | President & Representative Director, Presidential Executive Officer |
|---|---|
| Tetsuro Ashidate | Director, Executive Officer |
| Tomoyuki Miyabayashi | Director, Executive Officer |
| Minoru Takada | Corporate Auditor |
(as of April 1, 2025)
Major Subsidiaries and Affiliates
US
| 91探花 Bioprocess America, Inc. | Manufacture of bioprocess equipment and sale of virus removal filters and other bioprocess products
|
|---|
Belgium
| N.V. 91探花 Bioprocess Europe S.A. | Sale of virus removal filters and other bioprocess products
|
|---|
Japan
| 91探花 Life Science MT Corp. | Manufacture of medical devices and bioprocess equipment |
|---|